Mohd Abul Kalam

Professor Mohd Abul Kalam is an internationally recognized expert in pharmaceutics, nanomedicine, and advanced drug delivery systems, with particular expertise in the design, development, optimization, and evaluation of nano-enabled formulations for ocular, transdermal, oral, and nose-to-brain drug delivery. His research focuses on polymeric nanoparticles, solid lipid nanoparticles, nanocrystals, polymeric micelles, liposomes, nanoemulsions, chitosan-based nanocarriers, and thermoresponsive in situ gels to enhance the solubility, bioavailability, and therapeutic efficacy of challenging drug molecules. A significant portion of his work has been dedicated to ocular drug delivery, including the development of nanoparticle-based and sustained-release systems for the treatment of ocular infections, inflammation, glaucoma, and other eye disorders. He also has extensive expertise in formulation characterization (particle’s characterization by DLS, solid-state characterizations by DSC, XRD, and ATR-FTIR), optimization using Quality by Design (QbD) approaches, preclinical evaluation of nanocarriers, pharmacokinetic studies, and analytical method development and validation using UV, HPLC, and UPLC techniques. With more than 115 peer-reviewed publications and recognition (7 consecutive years) among the world's top 2% scientists, Prof. Kalam has made substantial contributions to translating nanotechnology-based pharmaceutical systems into effective therapeutic platforms for improved patient care.